We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Dutch self-regulatory body for pharmaceutical advertising, CGR, has, over the past years, developed standard case law pursuant to which comparative claims may only be made if reference is made to at least two independent comparative clinical studies that substantiate the claim
